Blog / Archives
Mid-Cap Biotechs Lead the Market: Pre-ASCO Scoreboard…Updates 6/4/18
6/4/18...after close Update-2...IBB down 0.65%, XBI down 0.22%. Momentum Waning Big Winners Today : BLUE, FMI, GHDX, IMMU, MRK It would appear that biotech stocks need to be bought prior to ASCO as...
Financial and Political Crisis in Italy Disrupts Biotech Stock Momentum…Updates with rally today 5/30
Updates 5/30 Pre-ASCO Rally: XBI regains momentum to $94 level. IBB breaks through SMA 200 level to $108+. Many mid-caps from our watch list soaring-CRSP*, FMI, FOLD, LGND, LOXO, NKTR, SGEN, SRPT...
Biotech Mid-Caps: The Momentum Trade is Back FMI, LOXO,XBI etc
Biotech Mid-Caps- Momentum Trade is Back ASCO Abstracts Provide Clinical Updates But as of 2 P EDT Stocks Are Being Hit By Profit Taking XBI at $92.39 Biotech mid-caps had a good week ending 5/18 as...
Biotechs Soar After Big Trump Drug Price Speech- Mid-Caps Should Outperform…Updates
Update: 5/17...Mini-Rally Continues With Help From ASCO Abstracts XBI hits $93.78 above April highs, up 5.32% over 5 days, 10.5% YTD. IBB at April highs at $107.59, up 3.62% over 5 days, up 0.77%...
Biotech Stocks Underperform Market: CELG, EXEL, PBYI, XBI…Updates 5/11…Big Rally on Drug Pricing Speech
Trump Speech on Plan for Lower Drug Prices 5/11 After close. Biotech and healthcare stocks were broadly higher. Key words by HHS Secretary were "complex" and "will take time"; more updates tomorrow....
Biotechs Survive 2018 Bottom and Catch a Rally Today…Update 5/9
Update 5/8/18 Biotechs Rally Above Near Term Support (XBI) at SMA 20 XBI up 1.96% to $89.80. IBB up 1.35% to $103.79; twelve month quadruple bottom is near $100 level. Small and mid caps should...
Biotechs Bounce From Support Levels Despite Mixed Earnings Reports…Update 5/3- Testing 2018 Lows
5/3 Testing February bottom and 200 MA of ~$100 on IBB and ~$85 on XBI. Red screen day. 2PM EDT Dow near flat line. Need to look for major gap up. Another potential negative on the horizon: "Bold...
2018 Biotech Sector Watch on Earnings #2: ABBV, ALXN, BMY…Updates VRTX
Update 4/30... Vertex Pharmaceuticals (VRTX) Beat Consensus by 4% Financial Results: CF Revenues rose 33% Q'18 o Q'17 from $481M to $638M; GAAP net income down 15% ,$210M from $241M. Two Phase 3...
2018 Biotech Sector Watch on Earnings #1: AMGN,BIIB…Updates
Update 4/25: Investors May See Value in Large Cap Biotech Amgen (AMGN) up 1.68%. Biogen (BIIB) holds Tuesday lows of $262 Up 2.78% today. IBB flat at $103.26 More earnings tomorrow but it is all...
Biotech and Pharma Stocks Await Q1 Earnings But Gene Editing Stocks Sell-Off
Speculative Biotech Stocks Sell-Off in Profit Taking: Gene Editing Biotech stocks held current levels but small caps and speculative stocks sold off with the XBI down 1%. Most large caps were in the...